Since PSA <3 ng/ml has a low positive predictive value (PPV) for detection of clinically significant prostate cancer among men with suspicious DRE, use of DRE as a “tool” in screening has mostly been recommended after an initial PSA screening test [4], [5], [6]. The gene discussed is KLK3; the disease is prostate carcinoma.